Pacific Biosciences Of California (PACB) Share-based Compensation (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Share-based Compensation of $4.5 million for Q1 2026, down 84.92% year-over-year from $29.6 million in Q1 2025, and down 53.49% quarter-over-quarter from $9.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Share-based Compensation (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Share-based Compensation history runs 17 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 84.92% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $16.6 million (down 79.59% YoY), while the FY2025 annual figure was $41.7 million, down 41.34% from the prior year.
- Share-based Compensation for Q1 2026 stood at $4.5 million, down from $9.6 million in the prior quarter.
- The five-year high for Share-based Compensation was $71.0 million in Q4 2024, with the low at -$36.7 million in Q3 2024.
- The 5-year median for Share-based Compensation is $17.2 million (2024), against an average of $13.8 million.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation soared 2009.79% in 2023, then plunged 286.6% in 2024.
- Pacific Biosciences Of California's Share-based Compensation stood at $18.0 million in 2022, then decreased by 7.64% to $16.6 million in 2023, then surged by 328.34% to $71.0 million in 2024, then slumped by 86.5% to $9.6 million in 2025, then sank by 53.49% to $4.5 million in 2026.
- Business Quant data shows PACB's Share-based Compensation at $4.5 million in Q1 2026, $9.6 million in Q4 2025, and $11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 9.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.26 Mn |
| Jun 30, 2026 | 9.26 Mn |
| Mar 31, 2026 | 4.46 Mn |
| Mar 31, 2026 | 4.46 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 10.98 Mn |
| Sep 30, 2025 | 10.98 Mn |
| Jun 30, 2025 | -8.48 Mn |
| Jun 30, 2025 | -8.48 Mn |
| Mar 31, 2025 | 29.58 Mn |
| Mar 31, 2025 | 29.58 Mn |
| Dec 31, 2024 | 71.04 Mn |
| Dec 31, 2024 | 71.04 Mn |
| Sep 30, 2024 | -36.74 Mn |
| Sep 30, 2024 | -36.74 Mn |
| Jun 30, 2024 | 17.22 Mn |
| Jun 30, 2024 | 17.22 Mn |
| Mar 31, 2024 | 19.53 Mn |
| Mar 31, 2024 | 19.53 Mn |